Brownstein Health Care Business Panel 2023: Threats and Opportunities
Our 2023 Health Care Business Panel looked at the top threats and opportunities in health care right now. The panelists covered the business outlook and dealmaking recalibration that is taking place in the health care industry, the regulatory power of the Biden administration and how they are looking to change health care, as well as antitrust issues, drug imports, telemedicine, generative AI and learnings from COVID-19.
Moderator:
Mike King, shareholder at Brownstein Hyatt Farber Schreck
Panelists:
Nadeam Elshami, policy director at Brownstein Hyatt Farber Schreck
Alex Geier, managing director at GLC Advisors & Co.
Deema Tarazi, senior policy advisor and counsel at Brownstein Hyatt Farber Schreck
This document is intended to provide you with general information regarding the business of health care. The contents of this document are not intended to provide specific legal advice. If you have any questions about the contents of this document or if you need legal advice as to an issue, please contact the attorneys listed or your regular Brownstein Hyatt Farber Schreck, LLP attorney. This communication may be considered advertising in some jurisdictions. The information in this article is accurate as of the publication date.
Recent Insights
Read MoreColorado Supreme Court Expands Public-Policy Exception to At-Will Employment
Presentation | June 22, 2026Data Hunger, Enterprise Risks: Biomedical Data and Cybersecurity in the AI Era
Client Alert | June 18, 2026NCUA and OCC Take Action to Preempt Illinois’ Interchange Law
Client Alert | June 17, 2026DOJ Opines that EEOC’s Title VII Disparate Impact Framework Is Unconstitutional
Presentation | June 17, 2026Biotech’s Legal and Regulatory Chaos
Client Alert | June 16, 2026G7 Leaders Launch Critical Minerals Resilience and Production Alliance
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.